[Enhanced targeted influenza vaccines - New evidence shows higher effectiveness in older adults]. / Weiterentwickelte zielgruppenorientierte Influenzaimpfstoffe Neue Evidenz zeigt höhere Effektivität bei älteren Erwachsenen.
Dtsch Med Wochenschr
; 148(9): 556-562, 2023 04.
Article
em De
| MEDLINE
| ID: mdl-36990440
ABSTRACT
Seasonal influenza causes a significant burden of disease in the German population and is associated with high societal costs. Persons aged 60 years and older are particularly at risk due to immunosenescence and chronic disease and account for a large proportion of influenza-associated hospitalizations and deaths. Adjuvanted, high-dose, recombinant and cell-based influenza vaccines have been developed to improve the effectiveness compared with conventional vaccines. Recent observational studies show better effectiveness of adjuvanted vaccine over conventional vaccines and similar effectiveness to the high-dose vaccine in older adults. Some countries have already considered the new evidence in their vaccination recommendations for the current or earlier seasons. The availability of the vaccines for older adults should also be ensured in Germany to guarantee a high level of vaccination protection.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra Influenza
/
Influenza Humana
/
Imunossenescência
Tipo de estudo:
Observational_studies
Limite:
Aged
/
Humans
/
Middle aged
Idioma:
De
Ano de publicação:
2023
Tipo de documento:
Article